General MedicationsINJECTIONGeneric
ZINC SULFATE
ZINC SULFATE
Standard Dose
EQ 1MG ZINC/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview ZINC SULFATE is listed in Drugs@FDA under application 019229 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient ZINC SULFATE Form and strength INJECTABLE;INJECTION - EQ 1MG ZINC/ML Sponsor ABRAXIS PHARM Submission history Latest submission status date: 1989-06-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview ZINC SULFATE is listed in Drugs@FDA under application 019229 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ZINC SULFATE Form and strength INJECTABLE;INJECTION - EQ 1MG ZINC/ML Sponsor ABRAXIS PHARM Submission history Latest submission status date: 1989-06-06 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.